Mylan's Aflibercept Biosimilar Gets Green Light For Trials In India

 
• By Anju Ghangurde
  
Green
Mylan's Biosimlar Rival To Eylea Gets Go Ahead For Phase III • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products